Revance Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Revance Therapeutics, Inc.
CIK #0001479290
EDGAR Form CIK 2011 - 2025
10-K [0001479290]
10-Q [0001479290]
3 [0001479290]
4 [0001479290]
8-K [0001479290]
D [0001479290]
SC 13D [0001479290]
SC 13G [0001479290]
Form 13D/13G Filer Form 13D/13G Subject Filed
JPMorgan Chase & Co Revance Therapeutics Inc [2025-02-11]
Glazer Capital LLC Revance Therapeutics Inc [2025-02-06]
Beryl Capital Management LLC Revance Therapeutics Inc [2025-01-10]
Beryl Capital Management LLC Revance Therapeutics Inc [2024-09-16]
Franklin Resources Inc Revance Therapeutics Inc [2024-02-06]
Teoxane Sa Revance Therapeutics Inc [2023-09-01]
Polar Capital Holdings PLC Revance Therapeutics Inc [2023-02-14]
Antara Capital LP Revance Therapeutics Inc [2023-02-14]
Capital World Investors Revance Therapeutics Inc [2022-02-11]
Vanguard Group Inc Revance Therapeutics Inc [2022-02-10]
View All
Form 3/4/5 Subject 2011 - 2025
Gangolli Julian S
Revance Therapeutics, Inc.
Moxie Dwight
Schilke Tobin
Foley Mark J
Russell Angus C.
Nolet Chris
Beraud Jill
Coric Vlad
Kolaja Carey OConnor
Ware Olivia C
Jordan Erica
Hollander David
Sjuts Dustin S
Vickers Philip J.
Rankin Aubrey
Joshi Abhay
Gardner Phyllis
Byrnes Robert F
McDowell Caryn Gordon
Browne L Daniel
Allouche Cyril
Zavodnick Todd Erik
Silvernail Lauren P
Eastman Ronald W
Ruegg Curtis
Prygocki Mark A SR
Glasheen James Walter
Bertolino Arthur Peter
NQ HCIF General Partner, L.P.
NQ HCIF GP, Ltd.
NovaQuest Pharma Opportunities Fund III, L.P.
Waugh Jacob
Wooten Ronald J
Tunnicliffe Jonathan
Essex Woodlands Health Ventures Fund VIII-B LP
Essex Woodlands Health Ventures Fund VIII-A LP
Essex Woodlands Health Ventures Fund VIII LP
Terms | Privacy | Guide
tony@aum13f.com